loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 9803a6ff 8a3e 4c64 B3d0 7825c7123bf2 Applno 206843 Form Tablet Oral Dosage Eq 30mg Base - Drug Product Composition: Daclatasvir Dihydrochloride

    Menu

    Daclatasvir Dihydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 840Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 206843 / DOSAGE - TABLET;ORAL - EQ 30MG BASE

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DACLATASVIR DIHYDROCHLORIDE(UNII: 50ZO25C11D)
    (DACLATASVIR - UNII:LI2427F9CI)     		DACLATASVIR30mg | 60mg | 90mg

    Inactive Ingredients

    Ingredient Name
    E.R. Squibb & Sons, L.L.C.
    ALUMINUM OXIDE(LMI26O6933)
    ANHYDROUS LACTOSE(3SY5LH9PMK)
    CROSCARMELLOSE SODIUM(M28OL1HH48)
    FD&C BLUE NO. 2(L06K8R7DQK)
    FERRIC OXIDE YELLOW(EX438O2MRT)
    HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
    INDIGOTINDISULFONATE SODIUM(D3741U8K7L)
    MAGNESIUM STEARATE(70097M6I30)
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
    POLYETHYLENE GLYCOL 400(B697894SGQ)
    SILICON DIOXIDE(ETJ7Z6XBU4)
    TITANIUM DIOXIDE(15FIX9V2JP)